Paclitaxel Kabi 6 mg/ml Solution for injection 25ml Vial
Product Details
Paclitaxel Kabi 6 mg/ml Solution for Injection is a critical medication primarily used in the treatment of various cancers, reflecting its potent antineoplastic properties. This sterile, clear solution is designed for intravenous administration, delivering the active ingredient, Paclitaxel, directly into the bloodstream. It is manufactured by Fresenius Kabi, a global leader in health care, ensuring high quality and adherence to pharmaceutical standards.
Benefits of Use
- Effective treatment for various types of cancer, including ovarian, breast, and non-small cell lung cancer.
- A cornerstone in many chemotherapy regimens, often used alone or in combination with other anti-cancer drugs.
- Aims to reduce tumor size, slow disease progression, and improve patient outcomes.
How to Use
- Preparation: The solution must be diluted before intravenous infusion, typically with 0.9% sodium chloride injection, 5% dextrose injection, 5% dextrose and 0.9% sodium chloride injection, or 5% dextrose in Ringer's injection.
- Administration Route: Administered as an intravenous infusion over a period of several hours.
- Dosage: The dosage and duration of treatment are highly individualized, determined by the patient's specific cancer type, stage, body surface area, and response to treatment.
- Monitoring: Patients will be closely monitored for adverse reactions during and after infusion.
Caution & Warnings
- Hypersensitivity Reactions: Severe hypersensitivity reactions can occur, characterized by dyspnoea, flushing, chest pain, and tachycardia. Patients should be premedicated to prevent these reactions.
- Bone Marrow Suppression: Myelosuppression, particularly neutropenia, is a dose-limiting toxicity. Complete blood counts should be monitored frequently.
- Peripheral Neuropathy: Development of peripheral neuropathy is common and may be dose-dependent.
- Cardiac Effects: Bradycardia, ECG abnormalities, and more rarely, myocardial infarction or congestive heart failure have been reported.
- Hepatic Impairment: Use with caution in patients with hepatic impairment, as exposure to paclitaxel may be increased.
- Pregnancy and Breastfeeding: Paclitaxel is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant.
- Storage: Store below 25°C. Do not refrigerate or freeze. Store in original container in order to protect from light.
- Disposal: Proper handling and disposal procedures for cytotoxic agents must be followed.
Ingredients
Active Ingredient: Paclitaxel 6 mg/ml
Excipients: Typically include Macrogol glycerol ricinoleate (e.g., Cremophor EL), dehydrated alcohol (ethanol), and anhydrous citric acid.
| Gtin | 603257003 |
|---|---|
| Recommended Sale Price | 778.45 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | PACLITAXEL |
| SFDA Reg. No | 603257003 |
| IBC | 603257003 |
| Drug Type | Prescription |
| Scientific Name | Paclitaxel |
| Strength | 6 mg/ml |
| Strength Unit | mg/ml |
| Form | Solution for injection |
| Admin Route | Intravenous |
| Size | 25ml |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 25ml |
| Storage conditions | Store below 25C. Do not refrigerate or freeze. Store in original container in order to protect from light. |
| Refrigerator Storage | No |

